• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧诱导因子-2α通过诱导肝细胞死亡促进肝纤维化。

Hypoxia-Inducible Factor-2α Promotes Liver Fibrosis by Inducing Hepatocellular Death.

作者信息

Mooli Raja Gopal Reddy, Mukhi Dhanunjay, Watt Mikayla, Nagati Veerababu, Reed Sara M, Gandhi Nikita K, Oertel Michael, Ramakrishnan Sadeesh K

机构信息

Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.

Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, PA 15261, USA.

出版信息

Int J Mol Sci. 2024 Dec 6;25(23):13114. doi: 10.3390/ijms252313114.

DOI:10.3390/ijms252313114
PMID:39684823
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11642083/
Abstract

The activation of hypoxia-inducible factors (HIF)-1α and 2α in the liver is closely linked to the progression of fatty liver diseases. Prior studies indicated that disrupting hepatocyte HIF-2α attenuates diet-induced hepatic steatosis, subsequently decreasing fibrosis. However, the direct role of hepatocyte HIF-2α in liver fibrosis has not been addressed. Hepatic HIF-2α expression was examined in mouse model of carbon tetrachloride (CCl)-induced liver fibrosis. Conditional hepatocyte knockout mice were employed to investigate the role of hepatocyte HIF-2α in fibrosis. Markers of apoptosis, proliferation, inflammation, and fibrosis were assessed through biochemical, molecular, and histological analyses. We found an induction of HIF-2α in CCL-injected liver injury and fibrosis mouse models. Hepatocyte-specific deletion of HIF-2α attenuated stellate cell activation and fibrosis, with no significant difference in inflammation. Disrupting hepatocyte HIF-2α led to reduced injury-mediated hepatocellular apoptosis. Surviving hepatocytes exhibited hypertrophy, which was strongly associated with the activation of c-JUN signaling. Our study demonstrates a direct role of hepatocyte HIF-2α in liver fibrosis by promoting hepatocyte apoptosis. The reduction in apoptosis and induction of hepatocyte hypertrophy following HIF-2α disruption is closely linked to enhanced c-JUN signaling, a survival mechanism in response to liver injury. These findings highlight HIF-2α as a potential therapeutic target for liver fibrosis.

摘要

肝脏中缺氧诱导因子(HIF)-1α和2α的激活与脂肪性肝病的进展密切相关。先前的研究表明,破坏肝细胞HIF-2α可减轻饮食诱导的肝脂肪变性,进而减少纤维化。然而,肝细胞HIF-2α在肝纤维化中的直接作用尚未得到探讨。在四氯化碳(CCl)诱导的肝纤维化小鼠模型中检测了肝脏HIF-2α的表达。采用条件性肝细胞敲除小鼠来研究肝细胞HIF-2α在纤维化中的作用。通过生化、分子和组织学分析评估细胞凋亡、增殖、炎症和纤维化的标志物。我们发现在注射CCl的肝损伤和纤维化小鼠模型中HIF-2α被诱导。肝细胞特异性缺失HIF-2α可减轻星状细胞激活和纤维化,炎症方面无显著差异。破坏肝细胞HIF-2α导致损伤介导的肝细胞凋亡减少。存活的肝细胞表现出肥大,这与c-JUN信号的激活密切相关。我们的研究表明肝细胞HIF-2α通过促进肝细胞凋亡在肝纤维化中起直接作用。HIF-2α破坏后凋亡减少和肝细胞肥大的诱导与增强的c-JUN信号密切相关,c-JUN信号是一种对肝损伤的存活机制。这些发现突出了HIF-2α作为肝纤维化潜在治疗靶点的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d103/11642083/c1c02deaa42f/ijms-25-13114-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d103/11642083/62c4e6386714/ijms-25-13114-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d103/11642083/eeb0e9d69f0c/ijms-25-13114-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d103/11642083/e8b4443adbbe/ijms-25-13114-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d103/11642083/78c7f2903e61/ijms-25-13114-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d103/11642083/9002cf06110e/ijms-25-13114-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d103/11642083/c1c02deaa42f/ijms-25-13114-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d103/11642083/62c4e6386714/ijms-25-13114-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d103/11642083/eeb0e9d69f0c/ijms-25-13114-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d103/11642083/e8b4443adbbe/ijms-25-13114-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d103/11642083/78c7f2903e61/ijms-25-13114-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d103/11642083/9002cf06110e/ijms-25-13114-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d103/11642083/c1c02deaa42f/ijms-25-13114-g006.jpg

相似文献

1
Hypoxia-Inducible Factor-2α Promotes Liver Fibrosis by Inducing Hepatocellular Death.缺氧诱导因子-2α通过诱导肝细胞死亡促进肝纤维化。
Int J Mol Sci. 2024 Dec 6;25(23):13114. doi: 10.3390/ijms252313114.
2
Hepatocyte-specific knockout of HIF-2α cannot alleviate carbon tetrachloride-induced liver fibrosis in mice.肝实质细胞特异性敲除 HIF-2α 不能减轻小鼠四氯化碳诱导的肝纤维化。
PeerJ. 2023 Apr 3;11:e15191. doi: 10.7717/peerj.15191. eCollection 2023.
3
Chronic intermittent hypoxia alleviates alcohol-related liver injury via downregulation of hepatic hypoxia-inducible factor-2α.慢性间歇性低氧通过下调肝脏缺氧诱导因子-2α减轻酒精相关性肝损伤。
Am J Physiol Gastrointest Liver Physiol. 2025 May 1;328(5):G610-G623. doi: 10.1152/ajpgi.00283.2024. Epub 2025 Apr 17.
4
Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation.肝细胞特异性敲除 HIF2α 通过降低癌细胞增殖预防 NASH 相关肝癌发生。
Cell Mol Gastroenterol Hepatol. 2022;13(2):459-482. doi: 10.1016/j.jcmgh.2021.10.002. Epub 2021 Oct 14.
5
Hypoxia-inducible factor-1 alpha (HIF-1α) inhibitor AMSP-30 m attenuates CCl-induced liver fibrosis in mice by inhibiting the sonic hedgehog pathway.缺氧诱导因子-1α(HIF-1α)抑制剂AMSP-30 m通过抑制音猬因子信号通路减轻CCl诱导的小鼠肝纤维化。
Chem Biol Interact. 2025 May 25;413:111480. doi: 10.1016/j.cbi.2025.111480. Epub 2025 Mar 18.
6
Reduction of hepatic fibrosis by overexpression of von Hippel-Lindau protein in experimental models of chronic liver disease.过表达 von Hippel-Lindau 蛋白减少慢性肝病实验模型中的肝纤维化。
Sci Rep. 2017 Jan 23;7:41038. doi: 10.1038/srep41038.
7
Hepatocyte HIF-2α aggravates NAFLD by inducing ferroptosis through increasing extracellular iron.肝细胞HIF-2α通过增加细胞外铁诱导铁死亡,从而加重非酒精性脂肪性肝病。
Am J Physiol Endocrinol Metab. 2025 Jan 1;328(1):E92-E104. doi: 10.1152/ajpendo.00287.2023. Epub 2024 Dec 16.
8
Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway.缺氧通过 HIF-2α/PPARα 通路加重非酒精性脂肪性肝病。
Am J Physiol Endocrinol Metab. 2019 Oct 1;317(4):E710-E722. doi: 10.1152/ajpendo.00052.2019. Epub 2019 Aug 20.
9
Hypoxia-inducible factor 2α mediates nonesterified fatty acids and hypoxia-induced lipid accumulation in bovine hepatocytes.缺氧诱导因子2α介导牛肝细胞中游离脂肪酸和缺氧诱导的脂质积累。
J Dairy Sci. 2025 Apr;108(4):4062-4078. doi: 10.3168/jds.2024-25839. Epub 2025 Jan 30.
10
Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease.肝细胞缺氧诱导因子-1介导非酒精性脂肪性肝病小鼠模型中肝纤维化的发展。
PLoS One. 2016 Dec 28;11(12):e0168572. doi: 10.1371/journal.pone.0168572. eCollection 2016.

引用本文的文献

1
A real-world pharmacovigilance study of belzutifan in renal cell carcinoma and von Hippel-Lindau disease: insights from the FDA adverse event reporting system database.一项关于贝佐蒂凡治疗肾细胞癌和冯·希佩尔-林道病的真实世界药物警戒研究:来自美国食品药品监督管理局不良事件报告系统数据库的见解
Int J Clin Pharm. 2025 Jun 16. doi: 10.1007/s11096-025-01953-9.
2
Parenteral Nutrition-Induced Liver Function Complications: Incidence, Risk Factors, and Prognosis.肠外营养诱导的肝功能并发症:发生率、危险因素及预后
J Clin Med. 2025 Feb 13;14(4):1220. doi: 10.3390/jcm14041220.

本文引用的文献

1
Modulating the HSP90 control over NFκB/NLRP3/Caspase-1 axis is a new therapeutic target in the management of liver fibrosis: Insights into the role of TAS-116 (Pimitespib).调控 HSP90 对 NFκB/NLRP3/Caspase-1 轴的控制是肝纤维化治疗的新靶点:TAS-116(Pimitespib)作用机制的研究进展。
Life Sci. 2024 Oct 1;354:122966. doi: 10.1016/j.lfs.2024.122966. Epub 2024 Aug 13.
2
Hepatocyte-specific CCAAT/enhancer binding protein α restricts liver fibrosis progression.肝特异性 CCAAT/增强子结合蛋白α限制肝纤维化进展。
J Clin Invest. 2024 Apr 1;134(7):e166731. doi: 10.1172/JCI166731.
3
CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis.
CD1d 可防止非酒精性脂肪性肝炎中的肝细胞凋亡。
J Hepatol. 2024 Feb;80(2):194-208. doi: 10.1016/j.jhep.2023.10.025. Epub 2023 Oct 28.
4
Programmed cell death in hepatic fibrosis: current and perspectives.肝纤维化中的程序性细胞死亡:现状与展望
Cell Death Discov. 2023 Dec 12;9(1):449. doi: 10.1038/s41420-023-01749-8.
5
Programmed Cell Death in Liver Fibrosis.肝纤维化中的程序性细胞死亡
J Inflamm Res. 2023 Sep 1;16:3897-3910. doi: 10.2147/JIR.S427868. eCollection 2023.
6
PLK1 and AURKB phosphorylate survivin differentially to affect proliferation in racially distinct triple-negative breast cancer.PLK1 和 AURKB 对 survivin 的磷酸化作用不同,从而影响不同种族的三阴性乳腺癌的增殖。
Cell Death Dis. 2023 Jan 10;14(1):12. doi: 10.1038/s41419-022-05539-5.
7
Loss of long-chain acyl-CoA synthetase 1 promotes hepatocyte death in alcohol-induced steatohepatitis.长链酰基辅酶 A 合成酶 1 的缺失促进酒精性脂肪性肝炎中的肝细胞死亡。
Metabolism. 2023 Jan;138:155334. doi: 10.1016/j.metabol.2022.155334. Epub 2022 Oct 28.
8
Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation.MLKL 的缺失通过抑制肝细胞坏死性凋亡和肝星状细胞激活来改善肝纤维化。
Theranostics. 2022 Jul 4;12(11):5220-5236. doi: 10.7150/thno.71400. eCollection 2022.
9
The multifaceted role of ferroptosis in liver disease.铁死亡在肝脏疾病中的多方面作用。
Cell Death Differ. 2022 Mar;29(3):467-480. doi: 10.1038/s41418-022-00941-0. Epub 2022 Jan 24.
10
HIF2α Activation in NASH: A New Force Pushing Toward HCC.非酒精性脂肪性肝炎中低氧诱导因子2α的激活:推动肝细胞癌发生的新力量。
Cell Mol Gastroenterol Hepatol. 2022;13(2):678-680. doi: 10.1016/j.jcmgh.2021.11.005. Epub 2021 Nov 27.